The Transportation Safety Board of Canada today has again called for implementation of a positive train control-type system ...

Pluvicto, Novartis’ blockbuster radiopharmaceutical for prostate cancer, has been greenlighted by the FDA for use earlier in ...

LifeMine restructures with layoffs; PTC's Translarna is pulled in Europe; Opthea ends AMD trials; Apollomics and LaunXP make ...

Shares of PTC Inc. PTC shed 3.44% to $154.80 Friday, on what proved to be an all-around grim trading session for the stock ...

The IRS has issued a crucial warning for taxpayers during the 2025 tax season. Understanding the circumstances that could ...

Korea Investment CORP increased its stake in PTC Inc. (NASDAQ:PTC – Free Report) by 79.8% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 77, ...

PTC Inc. PTC has officially launched Codebeamer 3.0, the latest version of its Application Lifecycle Management (“ALM”) ...

PTC Therapeutics said on Friday the European Commission will remove its inherited progressive muscle-wasting disorder from the region after an advisory panel reaffirmed a negative opinion of the drug ...

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on March 24, 2025, the company approved non-statutory stock options to purchase an aggregate of 12,000 shares of its common stock and 28,220 ...

PTC Inc. is expanding with cloud-native tools and AI integration. Learn why PTC stock is a solid "Buy" on dips, driven by ...

TD Cowen analyst Joseph Thome maintained a Hold rating on PTC Therapeutics (PTCT – Research Report) today and set a price target of $60.00. The ...

PTC Therapeutics (PTCT) announced that the European Commission has adopted the opinion of the Committee for Medicinal Products for Human Use of ...